Bal Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
BALPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bal Pharma Limited has informed the stock exchanges that its trading window will be closed starting 18 October 2025. The closure applies to designated persons and their immediate relatives, in line with SEBI's Insider Trading Regulations. The window will reopen 48 hours after the company declares its unaudited financial results for the quarter and half year ended 30 September 2025. The exact date of the board meeting to approve these results has not yet been announced and will be communicated later. This is a routine compliance measure taken by companies ahead of financial result announcements.
This is a standard regulatory filing and is neutral for shareholders. It signals that the company's Q2 and half-yearly results are likely due in late October 2025, which investors should watch for, but it carries no direct impact on the stock price.